Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
CompletedNCT00566631
What is this study about?Researchers studied Paliperidone to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including ZagrebSchizophreniaMedication studyAges 18+
- Countries
- France, Croatia, Germany, + 4 others
- Sponsor
- Janssen-Cilag International NV
CompletedNCT01299389
What is this study about?Researchers compared Paliperidone palmitate and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including FujiokaSchizophreniaMedication studyAges 20+
- Countries
- Japan, South Korea, Taiwan
- Sponsor
- Janssen Pharmaceutical K.K.
CompletedNCT01662310
Official study titlePaliperidone Extended Release Tablets for the Prevention of Relapse in Subjects With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
This study has finished and is no longer accepting participants.
Multiple locations, including BaodingSchizophreniaMedication studyAges 18+
- Countries
- China
- Sponsor
- Janssen Research & Development, LLC
CompletedNCT03865186
Official study titleAn Evaluation of a Psychoeducation Program for Emotion Identification and Expression in Individuals Diagnosed With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaBehavioural studyAges 18–60
- Countries
- Sponsor
- Kırıkkale University
TerminatedNCT00412620
What is this study about?Researchers are comparing ABT-925 and placebo to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study ended early.
Multiple locations, including AnaheimSchizophreniaMedication studyAges 18–65
- Countries
- United States, Argentina, Mexico
- Sponsor
- Abbott
TerminatedNCT05741502
Official study titleAn Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine Versus Non-Clozapine Antipsychotics in Individuals With Treatment-resistant Schizophrenia
This study ended early.
In ColumbusSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Ohio State University
CompletedNCT00996242
Official study titleAn Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In GothenburgSchizophreniaMedication studyAges 23–56
- Countries
- Sweden
- Sponsor
- Göteborg University
CompletedNCT00257023
What is this study about?This study evaluated the safety and effectiveness of paliperidone for people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 20–64
- Countries
- Sponsor
- Janssen Pharmaceutical K.K.
CompletedNCT01895452
What is this study about?Researchers compared ALKS 9072, Low Dose and ALKS 9072, High Dose, tracking side effects to assess long-term safety in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–70
- Countries
- United States, Bulgaria, Malaysia, + 5 others
- Sponsor
- Alkermes, Inc.
CompletedNCT01175135
What is this study about?Researchers compared PF-02545920, placebo and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–65
- Countries
- United States, Germany, Ukraine
- Sponsor
- Pfizer
CompletedNCT01634542
Official study titleA Non-Interventional Prospective Cohort Study of Patients With Persistent Symptoms of Schizophrenia to Describe The Course and Burden of Illness
This study has finished and is no longer accepting participants.
Multiple locations, including Buenos AiresSchizophreniaObservational studyAges 18+
- Countries
- France, Canada, United Kingdom, + 5 others
- Sponsor
- Hoffmann-La Roche
TerminatedNCT01894984
Official study titleClinical Observation of the Efficacy and Safety of Risperidone Long-Acting Injection (Risperdal Consta) in the Treatment of Schizophrenia in China
This study ended early.
Location not clearly listedSchizophreniaObservational studyAges 18–65
- Countries
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.